EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release

BACKGROUND: Characteristics of tumor microenvironment have been suggested as predictive markers of anti-EGFR or anti-HER2 treatment response. However, the effect of EGFR/HER2 signal blockade on the tumor immune microenvironment is unclear. METHODS: EGFR/HER2 pathway signaling and PD-L1 expression in...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, Koung Jin, Sung, Ji Hea, Kim, Jin Won, Han, Song-Hee, Lee, Hye Seung, Min, Ahrum, Kang, Mi Hyun, Kim, Ji Eun, Kim, Ji-Won, Kim, Se Hyun, Lee, Jeong-Ok, Kim, Yu Jung, Lee, Keun-Wook, Kim, Jee Hyun, Bang, Soo-Mee, Im, Seock-Ah, Lee, Jong Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609971/
https://www.ncbi.nlm.nih.gov/pubmed/28969039
http://dx.doi.org/10.18632/oncotarget.19194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609971/
https://www.ncbi.nlm.nih.gov/pubmed/28969039
http://dx.doi.org/10.18632/oncotarget.19194

Ejemplares similares